Product Images Insulin Glargine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 20 images provide visual information about the product associated with Insulin Glargine NDC 0955-1729 by Winthrop U.s., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - insulin 01

Chemical Structure - insulin 01

Figure 1 - insulin 02

Figure 1 - insulin 02

Image - insulin 03

Image - insulin 03

Image - insulin 04

Image - insulin 04

Image - insulin 05

Image - insulin 05

Image - insulin 06

Image - insulin 06

Image - insulin 07

Image - insulin 07

Image - insulin 08

Image - insulin 08

Image - insulin 09

Image - insulin 09

Image - insulin 10

Image - insulin 10

The text appears to be a diagram or illustration of a pen used for administering insulin. It includes various parts such as the pen cap, pen needle (which is not included), pen body, dose selector button, insulin reservoir, and a rubber seal. Additionally, there is a protective seal and the word "mecion" which may be a brand name or trademark.*

Image - insulin 11

Image - insulin 11

Image - insulin 12

Image - insulin 12

Image - insulin 13

Image - insulin 13

Image - insulin 14

Image - insulin 14

Image - insulin 15

Image - insulin 15

Image - insulin 16

Image - insulin 16

Image - insulin 17

Image - insulin 17

Image - insulin 18

Image - insulin 18

PRINCIPAL DISPLAY PANEL - One 10 mL Vial Carton - insulin 19

PRINCIPAL DISPLAY PANEL - One 10 mL Vial Carton - insulin 19

Insulin glargine injection is a medication used for subcutaneous injection to treat diabetes. It is available in a 10 mL multiple-dose vial and is only to be used with a U-100 syringe. The medication should not be mixed with other insulins and the solution must be clear and colorless with no visible particles. Insulin glargine must be refrigerated until opened and should be discarded 28 days after opening. The medication contains 100 units (36378 mg) insulin glargine, 30 meg 2nc, 2.7 mg m-cresol, 20 mg glycercl 85%, 20 mog plysotate 20, and water for injection. The pH is adjusted by adding aqueous solutions of hydrochloric acid and sodium hydovide. Dosage and administration instructions should be followed as per package directions and medical supervision must be sought if pregnant or nursing.*

PRINCIPAL DISPLAY PANEL - Five 3 mL Pen Carton - insulin 20

PRINCIPAL DISPLAY PANEL - Five 3 mL Pen Carton - insulin 20

Product description: Insulin glargine 100 IU/ml injection solostarĀ® U-100 micro fine disposable pen, manufactured by SanofiĀ®-Aventis. A carton contains five 3ml pre-filled pens, to be dispensed in the sealed carton. It should not be mixed with other insulin. It is intended for subcutaneous injection only. Users should ensure that the solution is clear and colorless with no particles before use. It is recommended to use the product within 28 days after the first use. Needles are not included.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.